Companies › ZURA

ZURA BIO LTD (ZURA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001855644 · EDGAR filings · Updated 2026-07-01

ZURA BIO LTD (ZURA) has reported institutional ownership of 69.3%, with 93 institutional managers holding positions valued at $390.1M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-01 — Current report (8-K) filed
• 2026-06-22 — Initial insider ownership filed (Form 3)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)
• 2026-06-22 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ZURA BIO LTD has 93 institutional holders and institutional ownership of 69.3%.

Insider activity

Insiders reported 1 transactions (1 buys, 0 sells) across 2 reporting insiders, with a net reported value of $12.5M.

Data flags from SEC filings

Related companies

UPSTREAM BIO INC (UPB) · DESIGN THERAPEUTICS INC (DSGN) · LARIMAR THERAPEUTICS INC (LRMR) · ZEVRA THERAPEUTICS INC (ZVRA) · ENGENE HOLDINGS INC (ENGN) · CRYOPORT INC (CYRX)